1. Vigan M. Cosmétovigilance en 2007. Revue française d'allergologie et d'immunologie clinique. 2007;47(3):228-31.
2. Vigan M, Castelain F. Cosmetovigilance: definition, regulation and use “in practice”. European Journal of Dermatology. 2014;24(6):643-9.
3. Wong G, King C. Immediate-type hypersensitivity and allergic contact dermatitis due to para-phenylenediamine in hair dye. Contact Dermatitis (01051873). 2003;48(3).
4. Zamorano-Carrillo A. Cosmetovigilancia en Latinoamérica. Revista de la OFIL. 2023;33(3):219-20.
5. Zia A, Nandave M, Kumar A. Current Challenges and Future Perspectives: Pharmacovigilance. Pharmacovigilance Essentials: Advances, Challenges and Global Perspectives. 2024:365-80.
6. Ribet V, Claudin LA, Brinio E, Berthier A, Millet V, Halbeher C, et al. Surveillance of dermo-cosmetic products: a global cosmetovigilance system to optimise product development and consumer safety. European Journal of Dermatology. 2021;31(4):463-9.
7. Vigan M. La mise en place d'un système de dermato-allergovigilance dans l'allergie de contact. Revue francaise d'allergologie et d'immunologie clinique. 2000;40(3):381-3.
8. Salverda JG, Bragt PJ, de Wit‐Bos L, Rustemeyer T, Coenraads PJ, Tupker RA, et al. Results of a cosmetovigilance survey in The Netherlands. Contact Dermatitis. 2013;68(3):139-48.
9. ALTIOKKA İ, Melike Ü. Safety in cosmetics and cosmetovigilance, current regulations in Türkiye. Turkish journal of pharmaceutical sciences. 2022;19(5):610.
10. Avenel-Audran M, Dutartre H, Goossens A, Jeanmougin M, Comte C, Bernier C, et al. Octocrylene, an emerging photoallergen. Archives of dermatology. 2010;146(7):753-7.
11. Berne B, Bostrom Å, Grahnen AF, Tammela M. Adverse effects of cosmetics and toiletries reported to the Swedish Medical Products Agency 1989–1994. Contact Dermatitis. 1996;34(5):359-62.
12. De Groot A, Nater J, van der Lender R, Rijcken B. Adverse effects of cosmetics and toiletries: a retrospective study in the general population. International journal of cosmetic science. 1987;9(6):255-9.
13. Fornasier G, Francescon S, Leone R, Baldo P. An historical overview over Pharmacovigilance. International journal of clinical pharmacy. 2018;40(4):744-7.
14. Heisterberg M, Menné T. Council Directive 76/768/EEC of 27 July 1976 on the approximation of the laws of the member states relating to cosmetic products. Official Journal of the European Union. 2003;262(9):169-200.
15. Köse Ö, Sabuncuoğlu S, Erkekoğlu P, Koçer-Gümüşel B. Kozmetovijilans: Avrupa ve Türkiye’deki güncel durumu, uygulamaları ve kozmetovijilans anketleri. FABAD J Pharm Sci. 2018;43(1):79-90.
16. Krasteva M, Bons B, Tozer S, Rich K, Hoting E, Hollenberg D, et al. Contact allergy to hair colouring products The cosmetovigilance experience of 4 companies (2003-2006). European Journal of Dermatology. 2010;20(1):85-95.
17. Lucca JM, Joseph R, Al Kubaish ZH, Al-Maskeen SM, Alokaili ZA. An observational study on adverse reactions of cosmetics: The need of practice the Cosmetovigilance system. Saudi Pharmaceutical Journal. 2020;28(6):746-53.
18. Moretti U, Velo G. Cosmetovigilance: the ‘beautiful’risk. Drug Safety. 2008;31(5):437-9.
19. Sautebin L. Understanding the adverse effects of cosmetics: a pilot project in cosmetovigilance. Drug safety. 2008;31(5):433-6.
20. Sportiello L, Cammarota S, de Portu S, Sautebin L. Notification of undesirable effects of cosmetics and toiletries. Pharmacological research. 2009;59(2):101-6.
21. Zweers P, Gilmour N, Hepburn P, Gerritsen R, Van Puijenbroek E. Causality methods in Cosmetovigilance: Comparison of Colipa and PLM versus global introspection. Regulatory Toxicology and Pharmacology. 2012;63(3):409-17.
22. Praveen J, Swaminathan TV. Cosmetovigilance: emerging safety trends. Indian J Pharm Pharmacol. 2023;10:132-41.
23. Vigan M. Réglementation européenne des cosmétiques. EMC-Dermatologie-Cosmétologie. 2004;1(3):154-63.
24. Yadav S, Sinha M, Taradia K, Sharma AK, Kulshreshtha M. Pharmacovigilance, Cosmetovigilance, Hemovigilance, and Materiovigilance in Healthcare domains. Journal of Medicine, Surgery, and Public Health. 2024:100175.
25. ResAP R. on a vigilance system for undesirable effects of cosmetic products (“cosmetovigilance”) in Europe in order to protect public health.
26. Sahoo B. Contact anaphylaxis due to hair dye. Contact Dermatitis. 2000;43:244.
27. Uter W, Arnold R, Wilkinson J, Shaw S, Perrenoud D, Rili C, et al. A multilingual European patch test software concept: WinAlldat/ESSCA. Contact Dermatitis. 2003;49(5):270-1.
28. Varjonen E, Petman L, Mäkinen‐Kiljunen S. Immediate contact allergy from hydrolyzed wheat in a cosmetic cream. Allergy. 2000;55(3):294-6.
29. Zakir K, Karataş Y, Pekkan G, GÜNGÖR ANÇ, Rahman H, Khan FU, et al. Use of Cosmetics and Adverse Cosmetic Events Among Female Nurses: Need for a Cosmetovigilance System. Turkish Journal of Pharmaceutical Sciences. 2024;21(4):284.
30. Barel AO, Paye M, Maibach HI. Handbook of cosmetic science and technology: CRC press; 2014.
31. Kornfeld‐Lecanu S, Zajaczkowski F, Dubourg S, Martin L, Lefort S, Siest S. Vigilance in industry: cosmetics and household cleaning products. Balance sheet of case report from 2005 to 2007. Clinical and experimental dermatology. 2010;35(8):874-80.
32. Esaram KR. Cosmetovigilance: Advancing Safety, Awareness, and Public Health. International Journal of Alternative and Complementary Medicine. 2025:6-11.
